Alumis Inc. Common Stock (ALMS) is a publicly traded Healthcare sector company. As of May 21, 2026, ALMS trades at $22.21 with a market cap of $2.70B and a P/E ratio of -12.17. ALMS moved +2.37% today. Year to date, ALMS is +165.22%; over the trailing twelve months it is +351.64%. Its 52-week range spans $2.76 to $30.60. Analyst consensus is strong buy with an average price target of $40.44. Rallies surfaces ALMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ALMS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $22.21 |
| Market Cap | $2.70B |
| P/E Ratio | -12.17 |
| EPS | $-1.78 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.60 |
| 52-Week Low | $2.76 |
| Volume | 422 |
| Avg Volume | 0 |
| Revenue (TTM) | $8.40M |
| Net Income | $-237.41M |
| Gross Margin | 0.00% |
9 analysts cover ALMS: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.44.